Norbrook’s factory in Newry
Former Norbrook chief executive Andrea Iucci
The chief executive of renowned Northern Ireland veterinary pharmaceutical firm Norbrook has stepped down, the company confirmed today.
Andrea Iucci became chief executive of the Newry business, founded by Lord Ballyedmond, in October 2023.
Norbook today confirmed the departure of Mr Iucci from the role, with former CEO Liam Nagle to fill in until a successor is appointed.
A Companies House filing stated that Mr Iucci’s appointment as a director had been terminated on October 1.
In a statement, Norbrook said: “Regrettably, Andrea Iucci, CEO of Norbrook Laboratories, tendered his resignation in July 2025.
“The board has already commenced the search for his successor and, in the meantime, Liam Nagle (non-executive chairman, and formerly CEO and chairman, Norbrook Laboratories) has taken on the role of executive chair to ensure continuity and a smooth transition to a new CEO.
“We thank Andrea for his contribution and wish him well for the future.”
Mr Iucci was interviewed in January by Ulster Business and commented on the company’s improved performance in 2024.
It had announced 180 redundancies in 2023 in response to a downturn in demand, while pre-tax profits had dropped from £21.3m to £3.9m in the year to July 2023.
However, global sales of customer orders for the second half of 2024 were up 16% on 2023, with profits for the year to July 2024 reaching £5.3m.
Mr Iucci told Ulster Business: “There was a massive amount of work from everybody in the company, to be honest.
“I’m impressed about the commitment, the resilience and the passion here. I thought as an Italian I was passionate until I met the people in Norbrook, Newry.
“They are very passionate about what they do. There was a lot of work behind the scenes to achieve this turnaround.”